Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy-A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin.

Deininger, Susanne; Törzsök, Peter; Oswald, David; Lusuardi, Lukas

Deininger, Susanne; Törzsök, Peter; Oswald, David; Lusuardi, Lukas.

Afiliação

Deininger S; Department of Urology and Andrology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria.
Törzsök P; Department of Urology and Andrology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria.
Oswald D; Department of Urology and Andrology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria.
Lusuardi L; Department of Urology and Andrology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria.

Cancers (Basel) ; 13(13)2021 Jun 26.

Article em En | MEDLINE | ID: mdl-34206980